NIH conference. Primary biliary cirrhosis and the complement system

Area of Science:

• Immunology
• Hepatology
• Biochemistry

Background:

• Primary biliary cirrhosis (PBC) is a chronic liver disease characterized by intrahepatic cholestasis and immune system dysfunction.
• The role of the complement system in PBC pathophysiology is not fully understood.
• Previous studies indicate defects in both humoral and cellular immunity in PBC patients.

Purpose of the Study:

• To evaluate the status of the complement system in patients with primary biliary cirrhosis.
• To investigate potential defects in complement component C3 metabolism and C3b-receptor-mediated clearance.
• To compare complement system abnormalities in PBC with those in HBsAg-negative chronic active hepatitis.

Main Methods:

• Assessed serum complement levels and C3 catabolism in PBC patients.
• Evaluated the clearance of sensitized erythrocytes by Kupffer cells, focusing on C3b receptors.
• Compared findings in PBC patients with a cohort of HBsAg-negative chronic active hepatitis patients.

Main Results:

• PBC patients exhibited striking abnormalities in serum complement levels.
• Marked hypercatabolism of C3, but not albumin, suggested chronic complement activation.
• A significant defect in the clearance of sensitized erythrocytes by Kupffer cell C3b receptors was identified in PBC.
• These complement defects were not observed in HBsAg-negative chronic active hepatitis.

Conclusions:

• The complement system appears to be chronically activated in primary biliary cirrhosis.
• Impaired C3b-receptor-mediated clearance by Kupffer cells is a key finding in PBC.
• These complement abnormalities suggest a significant role for the complement system in the pathophysiology of primary biliary cirrhosis.